In HCC, molecular indicators of prognosis include the proliferating cell nuclear antigen (PCNA), and matrix metalloproteinases (MMPs) enzymes have been associated with tumor progression, invasion, and metastasis, which can contribute to a worse prognosis [11]. This evidence concerns the gene PCNA and hepatocellular carcinoma.